Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes
about
Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routesUse of Reporter Genes in the Generation of Vaccinia Virus-Derived VectorsThe evolution of poxvirus vaccinesVaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of PlasmodiumInduction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculationThe influence of delivery vectors on HIV vaccine efficacyIL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenzaVaginal immunization to elicit primary T-cell activation and dissemination.Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cellsInclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.Intranasal delivery of vaccines against HIV.Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yGeneration of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virusProtective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.Influenza reverse genetics: dissecting immunity and pathogenesis.Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDSImmune response in rhesus macaques after mixed modality immunisations with DNA, recombinant adenovirus and recombinant gp120 from human immunodeficiency virus type 1.Recombinant influenza virus vectors
P2860
Q22241377-1B5F1E90-78A7-4859-9B23-C1541C51C19BQ26746915-A903945E-CA26-4C9B-8F1D-CD493A875401Q26995905-675B0BB0-9C01-4A8C-B611-DE287824616DQ28730541-9C127375-C85D-4432-9E7A-0702097288A8Q33611645-D0EBD65E-EA49-4759-89E3-93B661513F84Q33788701-8935F0F7-6EE2-458D-9C3A-B0687E06A1BAQ34077543-2BB0EF5A-27B1-444E-A987-E5AC9C5DC7A8Q34289072-5EEDF4DB-008A-4886-9056-91D58AB5F094Q35023393-89C1BF4D-D802-4F0F-BE6C-7E101A70D54CQ35069383-C96C59DD-5CC1-4C79-A08E-2919F0FE7B83Q35292450-80542E50-3651-45C0-98B0-E75A077693DDQ35883032-A04FF402-BDD3-4D32-8447-47EA10A1110DQ36409054-8D9D6E15-CA33-4F15-954C-7506581A6581Q36488676-CDA4BDF5-ED43-4FCC-9B11-6FF60BBEA176Q36541222-B043E39E-EA89-4787-9BA0-103FD51860DBQ36663607-DF3BDAAB-F7CB-4E95-A0A6-C8500D9E64CAQ36943971-68E0DCEB-C781-453E-A14E-E2FB451A794EQ37001511-9A1FBEB5-FA0A-42BB-8F46-55516397B3D5Q37256687-416F97CD-CBEB-4909-842A-1AA561867B2EQ37348513-B07C08E8-A013-4B0D-A5B1-FB5D1867501CQ37590335-8514C0D8-0860-43D0-9BAD-2D98E15913C1Q38188084-BC15C8EB-3171-4C0E-B800-7F3F9CF1861DQ42575428-02B0AEA9-364B-484F-883F-9642C4CC3A13Q45411816-5308FD6F-F21A-4D79-B09C-3FC1CDB79F27Q56877430-BFB2B345-01C5-452E-B596-2DB9F284AAB5
P2860
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Prime-boost immunization sched ...... itorectal draining lymph nodes
@en
Prime-boost immunization sched ...... torectal draining lymph nodes.
@nl
type
label
Prime-boost immunization sched ...... itorectal draining lymph nodes
@en
Prime-boost immunization sched ...... torectal draining lymph nodes.
@nl
prefLabel
Prime-boost immunization sched ...... itorectal draining lymph nodes
@en
Prime-boost immunization sched ...... torectal draining lymph nodes.
@nl
P2093
P2860
P921
P1433
P1476
Prime-boost immunization sched ...... itorectal draining lymph nodes
@en
P2093
José Luis Nájera
M Magdalena Gherardi
Mariano Esteban
Susana Guerra
P2860
P304
P356
10.1128/JVI.77.12.7048-7057.2003
P407
P577
2003-06-01T00:00:00Z